The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Circulating Matrix Metalloproteinases 1, 2, 9 and Their Inhibitors TIMP-1 and TIMP-2 as Serum Markers of Liver Fibrosis in Patients With Chronic Hepatitis C: Comparison With PIIINP and Hyaluronic Acid
Abstract
OBJECTIVES: Histological examination of liver biopsy is currently required in the management of patients with chronic hepatitis C. Our aim was to evaluate the diagnostic utility of a panel of circulating markers in detecting the stage of fibrosis. METHODS: One hundred and ninety four-patients who had undergone a percutaneous liver biopsy before antiviral treatment, and 194 age- and sex-matched healthy subjects were studied. Serum levels of hyaluronate, procollagen type III N-terminal peptide (PIIINP), matrix metalloproteinases (MMP)-1, MMP-2, MMP-9 and their tissue inhibitors of metalloproteinases (TIMP)-1 and TIMP-2 were determined by RIA and ELISA. Histological lesions were staged according to the METAVIR score. RESULTS: Hyaluronate, PIIINP, TIMP-1, and TIMP-2 serum levels were significantly higher in patients than in controls. Six markers were significantly correlated with fibrosis: MMP-2 (r = 0.28; p < 0.01), TIMP-1 (r = 0.42; p < 0.001), HA (r = 0.50; p < 0.001), PIIINP (r = 0.62; p < 0.0001), MMP-1 (r = -0.32; p < 0.01), and MMP-9 (r = -0.22; p < 0.05). By multivariate analysis, only PIIINP and MMP-1 were independently associated with fibrosis, and were combined using the equation of the logistic regression model. Using receiver-operating characteristics analysis, the area under the curve of the score to discriminate mild (FO/F1) from significant fibrosis (F2/F3/F4) was 0.82, with a sensitivity of 60% for a specificity of 92%. CONCLUSION: Our results suggest that combining two serum markers reflecting fibrogenesis (PIIINP) and fibrolysis (MMP-1) may provide a useful tool for evaluating liver fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wai, C.-T., Greenson, J. K., Fontana, R. J., Kalbfleisch, J. D., Marrero, J. A., Conjeevaram, H. S., & Lok, A. S.-F. (2003) · Hepatology · doi:10.1053/jhep.2003.50346 · Cited by 4,406
An Algorithm for the Grading of Activity in Chronic Hepatitis C
Bedossa, P., & Poynard, T. (1996) · Hepatology · doi:10.1002/hep.510240201 · Cited by 4,088
Natural history of liver fibrosis progression in patients with chronic hepatitis C
Poynard, T., Bedossa, P., & Opolon, P. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07642-8 · Cited by 3,011
(2012) · Hepatogastroenterology · doi:10.5754/hge12183 · Cited by 1,625
Imbert-Bismut, F., Ratziu, V., Pieroni, L., Charlotte, F., Benhamou, Y., & Poynard, T. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04258-6 · Cited by 1,433
Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model
Forns, X. (2002) · Hepatology · doi:10.1016/s0270-9139(02)00107-6 · Cited by 1,125
Practices of Liver Biopsy in France: Results of a Prospective Nationwide Survey
Cadranel, J.-F., Rufat, P., & Degos, F. (2000) · Hepatology · doi:10.1053/jhep.2000.16602 · Cited by 993
AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection
Sheth, S. (1998) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(97)00009-9 · Cited by 583
Noninvasive diagnosis of hepatic fibrosis or cirrhosis
Oberti, F., Valsesia, E., Pilette, C., Rousselet, M., Bedossa, P., Aube, C., Gallois, Y., Rifflet, H., Maiga, M., Penneau-Fontbonne, D., et al. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9352863 · Cited by 375
Expression of tissue inhibitor of metalloproteinases 1 and 2 is increased in fibrotic human liver
Benyon, R., Iredale, J., Goddard, S., Winwood, P., & Arthur, M. (1996) · Gastroenterology · doi:10.1053/gast.1996.v110.pm8608892 · Cited by 353
Pohl, A. (2001) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)03830-8 · Cited by 287
Poynard, T., McHutchison, J., Manns, M., Myers, R. P., & Albrecht, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50319 · Cited by 253
Bonacini, M., Hadi, G., Govindarajan, S., & Lindsay, K. L. (1997) · PubMed · Cited by 250
Rossi, E., Adams, L., Prins, A., Bulsara, M., de Boer, B., Garas, G., MacQuillan, G., Speers, D., & Jeffrey, G. (2003) · Clinical Chemistry · doi:10.1373/49.3.450 · Cited by 242
Guéchot, J., Laudat, A., Loria, A., Serfaty, L., Poupon, R., & Giboudeau, J. (1996) · Clinical Chemistry · doi:10.1093/clinchem/42.4.558 · Cited by 239
McHutchison, J. G., Blatt, L. M., De Medina, M., Craig, J. R., Conrad, A., Schiff, E. R., Tong, M. J., & Group, T. C. I. S. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02233.x · Cited by 229
Hahn-Dantona, E., Ruiz, J. F., Bornstein, P., & Strickland, D. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100121200 · Cited by 222
Poynard, T., Imbert‐Bismut, F., Ratziu, V., Chevret, S., Jardel, C., Moussalli, J., Messous, D., Degos, F., & for the GERMED cyt04 group (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00341.x · Cited by 219
Myers, R. P., Benhamou, Y., Imbert-Bismut, F., Thibault, V., Bochet, M., Charlotte, F., Ratziu, V., Bricaire, F., Katlama, C., & Poynard, T. (2003) · AIDS · doi:10.1097/00002030-200303280-00010 · Cited by 203
Kossakowska, A. E., Edwards, D. R., Lee, S. S., Urbanski, L. S., Stabbler, A. L., Zhang, C.-L., Phillips, B. W., Zhang, Y., & Urbanski, S. J. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65703-3 · Cited by 184
Takahara, T., Furui, K., Yata, Y., Jin, B., Zhang, L. P., Nambu, S., Sato, H., Seiki, M., & Watanabe, A. (1997) · Hepatology · doi:10.1002/hep.510260620 · Cited by 178
Boeker, K. H. W., Haberkorn, C. I., Michels, D., Flemming, P., Manns, M. P., & Lichtinghagen, R. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(01)00730-6 · Cited by 149
Soluble Low Density Lipoprotein Receptor-related Protein (LRP) Circulates in Human Plasma
Quinn, K., Grimsley, P. G., Dai, Y.-P., Tapner, M. J., Chesterman, C. N., & Owensby, D. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23946 · Cited by 148
Walsh, K. M., Timms, P., Campbell, S., Norman, R., Macsween, M., & Morris, A. J. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026630129025 · Cited by 144
MMP2 activation by collagen I and concanavalin A in cultured human hepatic stellate cells
Théret, N., Lehti, K., Musso, O. C., & Clément, B. (1999) · Hepatology · doi:10.1002/hep.510300236 · Cited by 140
Benyon, C. R., Hovell, C. J., Da Gaça, M., Jones, E. H., Iredale, J. P., & Arthur, M. J. P. (1999) · Hepatology · doi:10.1002/hep.510300431 · Cited by 134
Préaux, A.-M., Mallat, A., Nhieu, J. T. V., d’Ortho, M., Hembry, R. M., & Mavier, P. (1999) · Hepatology · doi:10.1002/hep.510300432 · Cited by 134
Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection
Wong, V. S., Hughes, V. F., Trull, A. K., Wight, D. G. D., Petrík, J., & Alexander, G. (1998) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1998.00100.x · Cited by 127
Lichtinghagen, R., Michels, D., Haberkorn, C. I., Arndt, B., Bahr, M., Flemming, P., Manns, M. P., & Boeker, K. H. W. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(00)00037-4 · Cited by 124
Noninvasive Prediction of Fibrosis in Patients With Chronic Hepatitis C
Thabut, D., Simon, M., Myers, R. P., Messous, D., Thibault, V., Imbert‐Bismut, F., & Poynard, T. (2003) · Hepatology · doi:10.1053/jhep.2003.50109 · Cited by 97
Guechot, J., Poupon, R. E., Giral, P., Balkau, B., GIBOUDEAU, J., & Poupon, R. Y. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80013-8 · Cited by 96
Callejas, N. A., Casado, M., Díaz-Guerra, M. J. M., Boscá, L., & Martín‐Sanz, P. (2001) · Hepatology · doi:10.1053/jhep.2001.23002 · Cited by 96
Théret, N., Musso, O. C., L’Helgoualc’h, A., & Clément, B. (1997) · PubMed Central · Cited by 96
Prothrombin index is an indirect marker of severe liver fibrosis
Croquet, V., Vuillemin, E., Ternisien, C., Pilette, C., Oberti, F., Gallois, Y., Trossaërt, M., Rousselet, M. C., Chappard, D., & Calès, P. (2002) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200210000-00015 · Cited by 89
Myers, R. P., Ratziu, V., Imbert‐Bismut, F., Charlotte, F., & Poynard, T. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05997.x · Cited by 88
Murawaki, Y., Ikuta, Y., Okamoto, K., Koda, M., & Kawasaki, H. (2001) · Journal of Gastroenterology · doi:10.1007/s005350170084 · Cited by 84
Regulation and Significance of Hepatocyte-Derived Matrix Metalloproteinases in Liver Remodeling
Haruyama, T., Ajioka, I., Akaike, T., & Watanabe, Y. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2837 · Cited by 79
Terada, T., & Nakanuma, Y. (1994) · Hepatology · doi:10.1002/hep.1840200219 · Cited by 66
Lichtinghagen, R., Huegel, O., Seifert‐Held, T., Haberkorn, C. I., Michels, D., Flemming, P., Bahr, M., & Boeker, K. H. W. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.2.183 · Cited by 65
Hispathology of chronic hepatitis C in relation to epidemiological factors
Delladetsima, J. K., Rassidakis, G. Z., Tassoppoulos, N. C., Papatheodoridis, G., Smyrnoff, T., & Vafiadis, I. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80182-6 · Cited by 60
ROC curves in evaluation of serum fibrosis indices for hepatic fibrosis
Zheng, M. (2002) · World Journal of Gastroenterology · doi:10.3748/wjg.v8.i6.1073 · Cited by 56
Comparison of matrix metalloproteinase expression in normal and cirrhotic human liver
Lichtinghagen, R., Breitenstein, K., Arndt, B., Kühbacher, T., & Böker, K. H. W. (1998) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s004280050149 · Cited by 52
Böker, K. H. W., Pehle, B., Steinmetz, C., Breitenstein, K., Bahr, M., & Lichtinghagen, R. (2000) · PubMed · Cited by 30
Serum hyaluronan as a marker of liver fibrosis in asymptomatic chronic viral hepatitis B
Pontinha, N., Pessegueiro, H., & Barros, H. (1999) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.1080/00365519950185535 · Cited by 29
Patel, K., Muir, A. J., & McHutchison, J. G. (2003) · Hepatology · doi:10.1053/jhep.2003.50159 · Cited by 28
Murawaki, Y., Ikuta, Y., Okamoto, K., Koda, M., & Kawasaki, H. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80040-3 · Cited by 27
Mitsuda, A., Suou, T., Ikuta, Y., & Kawasaki, H. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80230-5 · Cited by 26
α-Interferon Improves Liver Fibrosis in Chronic Hepatitis C
Serejo, F., Costa, A., Oliveira, A. G., Ramalho, F. J., Batista, A., & de Moura, M. C. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010649403659 · Cited by 23
Trinchet, J., Hartmann, D. J., Pateron, D., Munz‐Gotheil, C., Callard, P., Ville, G., & Beaugrand, M. (1992) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.1992.tb01388.x · Cited by 17
Shimizu, I., Omoya, T., Takaoka, T., Wada, S., Wada, H., Taoka, M., Hayashi, H., Hayashi, S., Honda, H., Sano, N., et al. (2001) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2001.02402.x · Cited by 9
Cited by
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.006 · Cited by 1,875
“HCV Fibrotest® (Biopredictive, Paris, France) patented formula combining α-2-macroglobulin, γGT, apolipoprotein A1, haptoglobin, total bilirubin, age and gender Forns Index = 7.811 - 3.131 x ln(platelet count) + 0.781 x ln(GGT) + 3.467 x ln(age) - 0.014 x (cholesterol) AST to Platelet Ratio (APRI) = AST (/ULN)/platele…”
InfluentialNoninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C
Castera, L. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.02.017 · Cited by 605
A novel panel of blood markers to assess the degree of liver fibrosis†
Calès, P., Oberti, F., Michalak, S., Hubert‐Fouchard, I., Rousselet, M., Konaté, A., Gallois, Y., Ternisien, C., Chevailler, A., & Lunel, F. (2005) · Hepatology · doi:10.1002/hep.20935 · Cited by 560
Chou, R., & Wasson, N. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-11-201306040-00005 · Cited by 370
Non-invasive diagnosis of liver fibrosis and cirrhosis
Lurie, Y. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11567 · Cited by 352
Metadata
- Authors
- Leroy, V., Monier, F., Bottari, S., Trocme, C., Sturm, N., Hilleret, M.-N., Morel, F., & Zarski, J.-P.
- Venue
- American Journal of Gastroenterology
- Published
- 2004-02
- Volume
- 99
- Issue
- 2
- Pages
- 271-279
- ISSN
- 0002-9270 (ISSN-L)
- 1572-0241
- OpenAlex
- W2085071775
- Cited by
- 255
- References
- 50
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.